Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check31 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check46 days agoChange DetectedOn November 22, 2024, new content was added, while a significant section detailing data download options and study information was removed on October 10, 2024.SummaryDifference14%
- Check53 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check60 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.SummaryDifference16%
- Check67 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.